PT  - JOURNAL ARTICLE
AU  - Chongliang Luo
AU  - Arielle Marks-Anglin
AU  - Rui Duan
AU  - Lifeng Lin
AU  - Chuan Hong
AU  - Haitao Chu
AU  - Yong Chen
TI  - Accounting for small-study effects using a bivariate trim and fill meta-analysis procedure
AID  - 10.1101/2020.07.27.20161562
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.27.20161562
4099  - http://medrxiv.org/content/early/2020/07/29/2020.07.27.20161562.short
4100  - http://medrxiv.org/content/early/2020/07/29/2020.07.27.20161562.full
AB  - In meta-analyses, small-study effects (SSE) refer to the phenomenon that smaller studies show different, often larger, treatment effects than larger studies, which may lead to incorrect, commonly optimistic estimates of treatment effects. Visualization tools such as funnel plots have been widely used to investigate the SSE in univariate meta-analyses. The trim and fill procedure is a non-parametric method to identify and adjust for SSE and is widely used in practice due to its simplicity. However, most visualization tools and SSE bias correction methods have been focusing on univariate outcomes. For a meta-analysis with multiple outcomes, the estimated number of trimmed studies by trim and fill for different outcomes may be different, leading to inconsistent conclusions. In this paper, we propose a bivariate trim and fill procedure to account for SSE in a bivariate meta-analysis. Based on a recently developed visualization tool of bivariate meta-analysis, known as the galaxy plot, we develop a sensible data-driven imputation algorithm for SSE bias correction. The method relies on the symmetry of the galaxy plot and assumes that some studies are suppressed based on a linear combination of outcomes. The studies are projected along a particular direction and the univariate trim and fill method is used to estimate the number of trimmed studies. Compared to the univariate method, the proposed method yields consistent conclusion about SSE and trimmed studies. The proposed approach is validated using simulated data and is applied to a meta-analysis of efficacy and safety of antidepressant drugs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNO funding related.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe antidepressant drug data is published and available from the Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32802-7/fulltext